Fig 1.
The algorithm of selection for eligible patients in this study. All H&E slides were reviewed by an experienced pathologist (DE Song).
FA, follicular adenoma; cPTC, classical papillary thyroid carcinoma; FVPTC, follicular variant papillary thyroid carcinoma; HA, Hurthle cell adenoma; SVPTC; solid variant papillary thyroid carcinoma; WIFTC, widely invasive follicular thyroid carcinoma.
Table 1.
Antibodies and conditions used in the study.
Fig 2.
CK expression in minimally invasive follicular thyroid carcinoma.
(A) Overview image of TMA slide stained by CK19, (B) negative staining and (C) positive staining for CK19 (immunohistochemistry, original magnification ×200).
Table 2.
Clinicopathologic characteristics of patients with distant metastasis.
Table 3.
Univariate and multivariate analysis of risk factors for distant metastasis.
Fig 3.
Comparison of recurrence free survival on basis of the presence of extensive vascular invasion.
Table 4.
Comparison of the expression of protein markers between the group with distant metastasis and without distant metastasis.
Table 5.
Comparison of the expression of protein markers at TMA analysis according to clinicopathologic characteristics.